ULBI experienced a dramatic $12.2M swing from profitability to significant losses while doubling its debt burden to $55M.
The company's complete reversal from $6.3M profit to $5.9M loss, combined with a 113% debt increase, signals serious operational deterioration. The substantial increases in R&D (+25.8%) and SG&A (+21.9%) expenses suggest either aggressive growth investments or cost control issues that are severely impacting profitability.
ULBI's financials show a company in distress with operating income plummeting from $10M to -$5.9M while expenses ballooned across all categories. The company doubled its debt to $55M and saw operating cash flow decline by 34% to $11M, though it managed to increase cash reserves to $9.3M. The dramatic swing from profitability to losses, combined with significant debt increases and rising operational expenses, creates a concerning financial picture that suggests either major operational challenges or poorly executing growth investments.
Net income declined 193.4% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Debt increased 113.6% — substantial leverage increase; assess whether deployed for growth or covering losses.
Capital expenditure jumped 100.4% — major investment cycle underway; assess returns on deployment.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Cash position surged 36.3% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow fell 33.9% — earnings quality concerns; investigate working capital changes and non-cash items.
Current liabilities rose 27.5% — increased short-term obligations, watch current ratio.
R&D investment increased 25.8% — signals commitment to future product development, though near-term margin impact.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →